Volume 5, Issue 3 (Summer 2016)                   J Occup Health Epidemiol 2016, 5(3): 135-142 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shafiepour M, Bidaki R, Hasibi E, Mokhtaree M. The prevalence of depression and related factors in diabetic patients referred to Rafsanjan diabetes center, Iran, 2016. J Occup Health Epidemiol 2016; 5 (3) :135-142
URL: http://johe.rums.ac.ir/article-1-192-en.html

Related article in
Google Scholar

1- Dept of. Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Research Center of Addiction and Behavioral Sciences, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd,Iran.
3- Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4- Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , mrmokhtaree@yahoo.com
Article history
Received: 2016/09/19
Accepted: 2016/12/6
ePublished: 2017/04/8
Abstract:   (6768 Views)

Background: The prevalence of diabetes mellitus (DM) is increasing, and thus, its mental consequences, such as depression, have an increasing trend. The goal of the present study was the determination of the prevalence of depression and some of its related factors in patients with type II DM who referred to the Diabetes Center of Rafsanjan, Iran, in the year 2016.

Materials and Methods: For this purpose, 194 patients with DM under care in the Diabetes Clinic of Ranfanjan University of Medical Sciences, Iran, were selected via simple random sampling method and filled a demographic form and the Beck Depression Inventory (BDI). Data were analyzed using chi-squared test.

Results: In this study, 67%, 24.7%, 6.2%, and 2.1% of the participants had no depression symptoms, mild depression, moderate depression, and severe depression. There was significant difference between the frequency of different depression severities based on age (P < 0.001), duration since disease diagnosis or treatment (P < 0.001), occupation (P = 0.011), education (P < 0.001), and type of treatment.

Conclusions: The rate of depression in patients with DM is relatively high and women, people with lower level of education, and the elderly, and homemakers are at greater risk which signifies the necessity of psychological and psychiatric consultation.

Full-Text [PDF 280 kb]   (991 Downloads) |   |   Full-Text (HTML)  (1070 Views)  

1. World health Organization. Global report on diabetes. World health Organization, Geneva, Switzerland; 2016. Available from: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf.
2. Surrena H. Handbook for Brunner & Suddarth's textbook of medical-surgical nursing. 12th ed. Philadelphia, United States: Lippincott Williams & Wilkins; 2010.
3. Faulkner MS. Quality of life for adolescents with type 1 diabetes: parental and youth perspectives. Pediatr Nurs 2003; 29(5):362-8.
4. Holt T, Kumar S. ABC of diabetes. 6th ed. Hoboken, New Jersey, United States: John Wiley & Sons, Inc; 2013
5. Askarishahi M, Malaki Moghadam H, Fallahzade H, Lotfi MH, Afkhami-Ardekani M. Trend analysis of the rate of mortality due to diabetes mellitus in Iran during the period of 2003-2010: A join point regression analysis. Journal of Occupational Health and Epidemiology 2014; 3(2):112-6.
6. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes 2004; 22(3):123-7.
7. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59(3):241-50.
8. Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004; 26(6):430-6.
9. Fleming GA, Jhee SS, Coniff RF, Riordan HJ, Marphy MF, kurts NM, et al. Optimizing therapeutic developments in diabetes. 1st ed. New York, United States: Greenwich Medical Media; 1999.
10. Lishman WA. Organic psychiatry: The psychological consequencesof cerebral disorder. 3rd ed. Hoboken, New Jersey, United States: John Wiley & Sons, Inc; 1998.
11. Husaini BA, Hull PC, Sherkat DE, Emerson JS, Overton MT, Craun C, et al. Diabetes depression, and healthcare utilization among African Americans in primary care. J Natl Med Assoc 2004; 96(4):476-84.
12. Abdoli S, Mardanian L, Mirzaei M. How public perceive diabetes: A qualitative study. Iran J Nurs Midwifery Res 2012; 17(5):370-4.
13. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20(4):585-90.
14. Sevinock L, Guney E, Uslu A, Baklaci F. Depression in a sample of Turkish type 2 diabetes patients. Eur Psychiatry 2001; 16(4):229-31.
15. Rajabi Gh. Psychometric properties of back depression inventory short from items (BDI-13). Psychological characters of Beck depression inventory, Short form. Developmental Psychology 2005; 1(4):291-8.
16. Jeeva F, Dickens Ch, Coventry P, Bundy Ch, Davies L. Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence. Int J Technol Assess Health Care 2013; 29(4):384-91.
17. Larijani B, Khoramshahee M, khaliligorgani M, Bandarian F, Akhondzadeh Sh. Association of depression and diabetes in the doctor shariati diabetes clinic and iranian diabetes association. J Diabetes Metab Disord 2004; 3(1):77-82.
18. Taziki SA, Bazrafsan HR, Behnampour N, Paviz M. Relationship between depressive’s symptoms and diabetes. Journal of Gorgan University of Medical Sciences 2001; 3(2):59-64.
19. Nejati Safa A, Larijani B, Shariati B, Amini H, Rezagholizadeh A. Depression, quality of life and glycemic control in patients with diabetes. J Diabetes Metab Disord 2007; 7(2):195-204.
20. Mazloomi SS, Mirzaee A, Mahmoodi S. Study of depression prevalence in the patients with type II diabetes referring to Yazd Diabetes Research Center in 2008. Tolooe Behdasht 2008; 7(1-2):30-5.
21. Mahmoodi A, Sharifi A. Comparison frequency and factors associated with depression in diabetics and non diabetics patients. Journal of Nursing and Midwifery Urmia University of Medical Sciences 2008; 6(2):88-93.
22. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010; 53(12):2480-6.
23. Ranjbar KH, Sharif F, Dezhbakhsh T. Frequency and severity of depression in diabetic adults using tablet and insulin. Medical Journal of Hormozgan University 2007; 10(4):363-9.
24. Swenson CJ, Baxter J, Shetterly SM, Scarbro SL, Hamman RF. Depressive symptoms in Hispanic and non-Hispanic white rural elderly: the san luis valley health and aging study. Am J Epidemiol 2000; 152(11):1048-55.
25. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25(3):464-70.
26. Sahota PK, Knowler WC, Looker HC. Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry 2008; 69(5):800-9.
27. Palinkas LA, Barrett-Connor E, Wingard DL. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med 1991; 8(6):532-9.
28. Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 2007; 7:186.
29. Taheri N, Hojjati H, Mousavi M, Afra A, Dehghan B. The survey of anxiety and depression prevalence in diabetic patient referred to Abadan Taleghani and Khorramshahr Valiasr hospitals in 2011. J Diabetes Nurs 2014; 1(2):21-31.
30. Friis R, Nanjundappa G. Diabetes, depression and employment status. Soc Sci Med 1986; 23(5):471-5.
31. Moayedi F, Zare S, Nikbakht A. Anxiety and depression in diabetic patient referred to Bandar Abbas diabetes clinic. Hormozgan Medical Journal 2015; 18(1):65-71.
32. Noh JH, Park JK, Lee HJ, Kwon SK, Lee SH, Park JH, et al. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: a Korean study. Diabetes Res Clin Pract 2005; 69(3):243-8.
33. Besharati M. The survey of effective factors on barriers to initiating insulin therapy in diabetic patients referred to diabetic center of Yazd in 2015 [MD thesis]. Rafsanjan: Rafsanjan University of Medical Sciences; 2016.

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Occupational Health and Epidemiology

Designed & Developed by : Yektaweb